• Idorsia Ltd demerges from Actelion and lists on SIX Swiss Exchange

    On June 16, 2017, having completed its demerger from Actelion Ltd, Idorsia Ltd (“Idorsia”) commenced trading on SIX Swiss Exchange. On its first day of trading, the shares of Idorsia Ltd opened at a price of CHF 10.00. Idorsia is an independent biopharmaceutical company specialized in the discovery, development and commercialization of small molecule therapeutics…


    Read more: Idorsia Ltd demerges from Actelion and lists on SIX Swiss Exchange